Tracking visceral fat reduction over the course of Semaglutide therapy is one of the most clinically meaningful ways to measure treatment efficacy
By day 56, you are likely injecting substantially degraded material
10.1016/j.ccr.2012.02.014 226 WeiD.ChenD.MouH.ChakrabortyS.WeiB.TanL.et al (2023)
Cagrilintide has undergone extensive research in both monotherapy and combination protocols, particularly with semaglutide, showing remarkable synergistic effects that surpass the benefits of either compound alone
Your bodys tolerance may have decreased, and your provider might recommend restarting at a lower dose to avoid severe side effects
Diabetes 2026, 75 DOI: 10.2337/db26-2637-p.Peer-Reviewed Original ResearchConceptsII trialEfficacy of high dosePhase 3 registration trialsEfficacy of dosesTEAE-related discontinuationsWeight-related comorbidityPhase 2 trial resultsBody-weight reductionBody weight lossAbbVie Inc.Dose armMean BMIOnce-DailyGLP-1RAHigh dosesInterim analysisDoseObesityWeight lossPlaceboWeeksEfficacyTrial durationRe-randomizedAmgen Inc